Markets turn cautious, reversing an early gain to end lower
NEW YORK — Markets turned cautious again, erasing and early gain and ending lower as investors try to handicap how much the new coronavirus variant will impact the economy. The latest roller-coaster ride brought the S&P 500 index up 1.9% in the morning and down 1.2% by the closing bell. The afternoon reversal is the latest dizzying move in recent days as the omicron variant spreads. Wall Street was already headed lower in the afternoon when the White House announced that the first confirmed case with the omicron variant had been found in the U.S., in a person who recently returned from South Africa.
THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below.
Wall Street has investors on another roller-coaster ride Wednesday, as an early stock market rally reversed course and left indexes with more losses.
The S&P 500 was down 0.5% as of 3:24 p.m. Eastern. It had been 1.9% higher in the early going following some better-than-expected readings on the U.S. economy. The afternoon reversal is the latest dizzying move for Wall Street’s benchmark, which sank 2.3% on Friday for its worst loss since February, only to then rise 1.3% on Monday and then fall 1.9% on Tuesday.
The wild movements are partly the result of investors struggling to handicap how much damage the newest coronavirus variant will do to the economy. Markets were already headed lower Wednesday afternoon when the White House announced that the first case of the omicron variant had been found in the U.S., in a person who recently had returned from South Africa.
“Investors are going to have to get used to the idea that this is not going to be the last variant,” said Liz Young, chief investment strategist at SoFi. “This is likely something that is with us for a while and we have to learn to live with it and manage growth from an investment standpoint.”
Another weight dropped on Wall Street Tuesday when the head of the Federal Reserve said that it may halt its immense support for financial markets sooner than expected amid persistently high inflation sweeping the world.
But since climbing out of its early 2020 collapse caused by the first wave of COVID-19, one hallmark of the stock market’s powerful run has been the continued willingness by bargain-hunting investors to buy following any dip in prices. That lasting habit has helped the S&P 500 set 66 all-time highs so far in 2021, the second-most on record for a year, according to S&P Dow Jones Indices.
It also helped the Dow Jones Industrial Average initially climb 520 points Wednesday. The blue chip index lost that gain and more by late afternoon. It was down 236 points, or 0.7%, to 34,255. The Nasdaq composite also flipped to the red, sliding 1.2% after having been up 1.8% earlier in the day.
Longer-term Treasury yields also initially recovered some of their sharp drops from the day before, triggered by worries about slowing economic growth. But the rebound was short-lived. The yield on the 10-year Treasury was at 1.43% from 1.44% late Tuesday, when it fell from 1.52%.
Some better-than-expected data on the economy failed to avert the late-day wave of selling. A report from the Institute for Supply Management showed that growth in the U.S. manufacturing sector accelerated a touch faster last month than economists expected.
A separate report from payroll processor ADP said that non-government employers hired more people in November than economists expected. That could raise expectations for Friday’s more comprehensive jobs report from the U.S. government, though the ADP report doesn’t have a perfect track record predicting it.
A stronger economy would burn more fuel, and crude oil prices initially rose, briefly sending Benchmark U.S. crude 2.1% higher. But it shed those gains, closing down 0.9% at $65.57 per barrel. It momentarily dropped below $65 the day before. Brent crude, the international standard, slipped 0.5%.
The slide in oil prices pushed most energy stocks lower. Occidental Petroleum fell 1.9% and Diamondback Energy slid 2.3%.
Vertex Pharmaceuticals rallied 8.2% for the biggest individual gain in the S&P 500 after it reported encouraging data from a study of its investigational treatment for kidney disease. More than 57% of stocks in the S&P 500 fell.
Stocks rose across Europe and Asia amid the continuing uncertainty about how powerful omicron’s punch will be.
Japan’s Nikkei 225 rose 0.4% even as the country further tightened restrictions by asking international airlines to stop taking new reservations for all flights heading there until the end of the year.
South Korea’s Kospi jumped 2.1%, while Germany’s DAX returned 2.5%.
A measure of fear on Wall Street climbed 4.4%. The VIX, which shows how worried investors are about upcoming drops for the S&P 500, is still well above where it was before omicron walloped markets worldwide after Thanksgiving.
The possibility of less help for markets from the Fed continues to hang over Wall Street. Chair Jerome Powell said Tuesday the central bank will consider an earlier halt to its monthly purchases of bonds, which are meant to goose the economy by keeping rates low for mortgages and other long-term loans.
That would open the door for the Fed to raise short-term interest rates, diluting one of the main reasons for the S&P 500’s more than doubling since late March 2020. Low rates encourage investors to pay higher prices for stocks and have helped deflect criticism that the market had become too expensive. So a faster ramp up in short-term rates threatens stocks, but analysts say it could also be an encouraging signal about the Fed’s confidence in the economy’s strength.
Analysts also warn that the market is likely to remain jumpy until more clarity arrives on omicron’s ultimate impact. With no answer yet on the effectiveness of vaccines against the variant, it’s only a guess on whether governments will reinstate tough restrictions, people will be scared away from businesses or inflation will worsen.
———
AP Business Writrer Yuri Kageyama contributed.